Looking at the "Deep CNS Pipeline" above (thanks turbo), it reminded me of Acadia's own PWS investigative drug. Could taking PWS off the table by neuren have anything to do with a deal with Acadia? I know we have been given reasons by Jon, but Im positive there are other reasons that don't sound quite so altruistic in the background.
- Forums
- ASX - By Stock
- NEU
- Pipeline-in-a-drug
Pipeline-in-a-drug, page-148
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.67 |
Change
-1.045(6.25%) |
Mkt cap ! $2.000B |
Open | High | Low | Value | Volume |
$16.61 | $16.65 | $15.54 | $5.349M | 337.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 435 | $15.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.67 | 23 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 522 | 15.670 |
7 | 916 | 15.660 |
20 | 1170 | 15.650 |
9 | 1477 | 15.640 |
7 | 1379 | 15.630 |
Price($) | Vol. | No. |
---|---|---|
15.690 | 322 | 5 |
15.700 | 422 | 8 |
15.710 | 390 | 6 |
15.720 | 369 | 3 |
15.730 | 1317 | 6 |
Last trade - 14.59pm 18/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online